Birgit A Damoiseaux-Volman1, Stephanie Medlock2, Kimmy Raven2, Danielle Sent2, Johannes A Romijn3, Nathalie van der Velde4, Ameen Abu-Hanna2. 1. Amsterdam UMC, Department of Medical Informatics, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. b.a.damoiseaux@amsterdamumc.nl. 2. Amsterdam UMC, Department of Medical Informatics, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. 3. Amsterdam UMC, Department of Medicine, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. 4. Amsterdam UMC, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Abstract
PURPOSE: To investigate prevalence, independent associations, and variation over time of potentially inappropriate prescriptions in a population of older hospitalized patients. METHODS: A longitudinal study using a large dataset of hospital admissions of older patients (≥ 70 years) based on an electronic health records cohort including data from 2015 to 2019. Potentially inappropriate medication (PIM) and potential prescribing omission (PPO) prevalence during hospital stay were identified based on the Dutch STOPP/START criteria v2. Univariate and multivariate logistic regression were used for analyzing associations and trends over time. RESULTS: The data included 16,687 admissions. Of all admissions, 56% had ≥ 1 PIM and 58% had ≥ 1 PPO. Gender, age, number of medications, number of diagnoses, Charlson score, and length of stay were independently associated with both PIMs and PPOs. Additionally, number of departments and number of prescribing specialties were independently associated with PIMs. Over the years, the PIM prevalence did not change (OR = 1.00, p = .95), whereas PPO prevalence increased (OR = 1.08, p < .001). However, when corrected for changes in patient characteristics such as number of diagnoses, the PIM (aOR = 0.91, p < .001) and PPO prevalence (aOR = 0.94, p < .001) decreased over the years. CONCLUSION: We found potentially inappropriate prescriptions in the majority of admissions of older patients. Prescribing relatively improved over time when considering complexity of the admissions. Nevertheless, the high prevalence shows a clear need to better address this issue in clinical practice. Studies seeking effective (re)prescribing interventions are warranted.
PURPOSE: To investigate prevalence, independent associations, and variation over time of potentially inappropriate prescriptions in a population of older hospitalized patients. METHODS: A longitudinal study using a large dataset of hospital admissions of older patients (≥ 70 years) based on an electronic health records cohort including data from 2015 to 2019. Potentially inappropriate medication (PIM) and potential prescribing omission (PPO) prevalence during hospital stay were identified based on the Dutch STOPP/START criteria v2. Univariate and multivariate logistic regression were used for analyzing associations and trends over time. RESULTS: The data included 16,687 admissions. Of all admissions, 56% had ≥ 1 PIM and 58% had ≥ 1 PPO. Gender, age, number of medications, number of diagnoses, Charlson score, and length of stay were independently associated with both PIMs and PPOs. Additionally, number of departments and number of prescribing specialties were independently associated with PIMs. Over the years, the PIM prevalence did not change (OR = 1.00, p = .95), whereas PPO prevalence increased (OR = 1.08, p < .001). However, when corrected for changes in patient characteristics such as number of diagnoses, the PIM (aOR = 0.91, p < .001) and PPO prevalence (aOR = 0.94, p < .001) decreased over the years. CONCLUSION: We found potentially inappropriate prescriptions in the majority of admissions of older patients. Prescribing relatively improved over time when considering complexity of the admissions. Nevertheless, the high prevalence shows a clear need to better address this issue in clinical practice. Studies seeking effective (re)prescribing interventions are warranted.
Authors: Xiao Xuan Xing; Chen Zhu; Hua Yu Liang; Ke Wang; Yan Qi Chu; Li Bo Zhao; De Chun Jiang; Yu Qin Wang; Su Ying Yan Journal: Ann Pharmacother Date: 2019-05-25 Impact factor: 3.154
Authors: Anne Spinewine; Kenneth E Schmader; Nick Barber; Carmel Hughes; Kate L Lapane; Christian Swine; Joseph T Hanlon Journal: Lancet Date: 2007-07-14 Impact factor: 79.321
Authors: Denis O'Mahony; David O'Sullivan; Stephen Byrne; Marie Noelle O'Connor; Cristin Ryan; Paul Gallagher Journal: Age Ageing Date: 2014-10-16 Impact factor: 10.668
Authors: Birgit A Damoiseaux-Volman; Kimmy Raven; Danielle Sent; Stephanie Medlock; Johannes A Romijn; Ameen Abu-Hanna; Nathalie van der Velde Journal: Age Ageing Date: 2022-01-06 Impact factor: 10.668
Authors: Aino L Andersen; Morten B Houlind; Rikke L Nielsen; Lillian M Jørgensen; Charlotte Treldal; Morten Damgaard; Anne Kathrine Bengaard; Helle Gybel Juul-Larsen; Louise Bolvig Laursen; Esben Iversen; Marie Kruse; Anne M L Pedersen; Mads Hornum; Anne M Beck; Mette M Pedersen; Mikkel Z Ankarfeldt; Janne Petersen; Ove Andersen Journal: Trials Date: 2021-09-14 Impact factor: 2.279
Authors: Bastiaan T G M Sallevelt; Corlina J A Huibers; Jody M J Op Heij; Toine C G Egberts; Eugène P van Puijenbroek; Zhengru Shen; Marco R Spruit; Katharina Tabea Jungo; Nicolas Rodondi; Olivia Dalleur; Anne Spinewine; Emma Jennings; Denis O'Mahony; Ingeborg Wilting; Wilma Knol Journal: Drugs Aging Date: 2021-12-08 Impact factor: 3.923